Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA)
Clinical trial NCT03732391 · COMPLETED
Trial details
- NCT number
- NCT03732391
- Sponsor
- CORTESI LAURA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-12
- Primary completion
- 2022-06-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.